These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 35767454)

  • 1. Mitapivat versus Placebo for Pyruvate Kinase Deficiency. Reply.
    Al-Samkari H; Beynon V; van Beers EJ
    N Engl J Med; 2022 Jun; 386(26):2539. PubMed ID: 35767454
    [No Abstract]   [Full Text] [Related]  

  • 2. Mitapivat versus Placebo for Pyruvate Kinase Deficiency.
    Shah AJ; Schwartz JD; Segovia JC
    N Engl J Med; 2022 Jun; 386(26):2538-2539. PubMed ID: 35767453
    [No Abstract]   [Full Text] [Related]  

  • 3. Bone mineral density in adult patients with pyruvate kinase deficiency on long-term mitapivat treatment.
    Al-Samkari H; Grace RF; Glenthøj A; Andres O; Barcellini W; Galacteros F; Kuo KHM; Layton DM; Morado M; Viprakasit V; Tai F; Urbstonaitis R; Morales J; McGee B; Beers EJV
    Haematologica; 2024 Mar; 109(3):963-967. PubMed ID: 37731369
    [No Abstract]   [Full Text] [Related]  

  • 4. Mitapivat for treatment of pyruvate kinase deficiency.
    Costa FF
    Lancet Haematol; 2022 Oct; 9(10):e708-e709. PubMed ID: 35988547
    [No Abstract]   [Full Text] [Related]  

  • 5. Safety and Efficacy of Mitapivat in Pyruvate Kinase Deficiency.
    Grace RF; Rose C; Layton DM; Galactéros F; Barcellini W; Morton DH; van Beers EJ; Yaish H; Ravindranath Y; Kuo KHM; Sheth S; Kwiatkowski JL; Barbier AJ; Bodie S; Silver B; Hua L; Kung C; Hawkins P; Jouvin MH; Bowden C; Glader B
    N Engl J Med; 2019 Sep; 381(10):933-944. PubMed ID: 31483964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitapivat versus Placebo for Pyruvate Kinase Deficiency.
    Al-Samkari H; Galactéros F; Glenthøj A; Rothman JA; Andres O; Grace RF; Morado-Arias M; Layton DM; Onodera K; Verhovsek M; Barcellini W; Chonat S; Judge MP; Zagadailov E; Xu R; Hawkins P; Beynon V; Gheuens S; van Beers EJ;
    N Engl J Med; 2022 Apr; 386(15):1432-1442. PubMed ID: 35417638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitapivat improves ineffective erythropoiesis and iron overload in adult patients with pyruvate kinase deficiency.
    van Beers EJ; Al-Samkari H; Grace RF; Barcellini W; Glenthøj A; DiBacco M; Wind-Rotolo M; Xu R; Beynon V; Patel P; Porter JB; Kuo KHM
    Blood Adv; 2024 May; 8(10):2433-2441. PubMed ID: 38330179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitapivat in adult patients with pyruvate kinase deficiency receiving regular transfusions (ACTIVATE-T): a multicentre, open-label, single-arm, phase 3 trial.
    Glenthøj A; van Beers EJ; Al-Samkari H; Viprakasit V; Kuo KHM; Galactéros F; Chonat S; Porter J; Zagadailov E; Xu R; Oluyadi A; Hawkins P; Gheuens S; Beynon V; Barcellini W;
    Lancet Haematol; 2022 Oct; 9(10):e724-e732. PubMed ID: 35988546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of Pyruvate Kinase Deficiency.
    Gallagher PG; Glader B
    Pediatr Blood Cancer; 2016 May; 63(5):771-2. PubMed ID: 26836632
    [No Abstract]   [Full Text] [Related]  

  • 10. Pyruvate kinase deficiency and severe congenital hemolytic anemia in a double heterozygous patient with paternal transmission of an early germ-line de novo mutation.
    Mañú-Pereira Mdel M; Gonzalez-Roca E; van Solinge WW; Llaudet-Planas E; Sevilla J; Montllor L; Mensa-Vilaro A; Ploos van Amstel HK; van Wijk R; Vives-Corrons J
    Am J Hematol; 2015 Dec; 90(12):E217-9. PubMed ID: 26315463
    [No Abstract]   [Full Text] [Related]  

  • 11. Pyruvate kinase deficiency: clinical expression and new therapies.
    Al-Samkari H
    Clin Adv Hematol Oncol; 2022 Jul; 20(7):422-425. PubMed ID: 35802872
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinically meaningful improvements in patient-reported outcomes in mitapivat-treated patients with pyruvate kinase deficiency.
    Kuo KHM; Grace RF; van Beers EJ; Barcellini W; Glenthøj A; Holzhauer S; Beynon V; Morris S; Li J; Zagadailov E; Patel P; Al-Samkari H
    Am J Hematol; 2024 Jul; 99(7):1415-1419. PubMed ID: 38712615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel PLKR mutations in four families with pyruvate kinase deficiency.
    Qin L; Nie Y; Chen L; Zhang D; Lin Y; Ru K
    Int J Lab Hematol; 2020 Apr; 42(2):e84-e87. PubMed ID: 31747117
    [No Abstract]   [Full Text] [Related]  

  • 14. RLS with PLMS in a child with hemolytic anemia caused by pyruvate kinase deficiency.
    Peraita-Adrados R; Medrano-Martinez P; Peirano P; Algarín C; Lillo-Triguero L
    Sleep Med; 2020 May; 69():100-102. PubMed ID: 32062035
    [No Abstract]   [Full Text] [Related]  

  • 15. Pyruvate kinase deficiency in a newborn with extramedullary hematopoiesis in the skin.
    Voit RA; Grace RF
    Blood; 2020 Aug; 136(6):770. PubMed ID: 32761227
    [No Abstract]   [Full Text] [Related]  

  • 16. [PYRUVATE KINASE DEFICIENCY HEREDITARY NONSPHEROCYTIC HEMOLYTIC ANEMIA. REPORT OF TWO CASES IN A JAPANESE FAMILY AND REVIEW OF LITERATURE].
    MIWA S; NAGATA M
    Nihon Ketsueki Gakkai Zasshi; 1965 Feb; 28():1-13. PubMed ID: 14346355
    [No Abstract]   [Full Text] [Related]  

  • 17. Tanaka KR, Valentine WN, Miwa S. Pyruvate kinase (PK) deficiency hereditary nonspherocytic hemolytic anemia. Blood. 1962;19(3):267-295.
    Blood; 2016 May; 127(21):2505. PubMed ID: 27231390
    [No Abstract]   [Full Text] [Related]  

  • 18. [Case report of a family with erythrocyte pyruvate kinase deficiency].
    Pan YP; Yao HX
    Zhonghua Xue Ye Xue Za Zhi; 2019 Sep; 40(9):749. PubMed ID: 31648476
    [No Abstract]   [Full Text] [Related]  

  • 19. Who should be eligible for gene therapy clinical trials in red blood cell pyruvate kinase deficiency (PKD)?: Toward an expanded definition of severe PKD.
    Schwartz JD; Barcellini W; Grace RF; Bianchi P; Zanella A; López Lorenzo JL; Sevilla J; Shah AJ; Glader B; Nicoletti E; Navarro Ordoñez S; Segovia JC
    Am J Hematol; 2022 Mar; 97(3):E120-E125. PubMed ID: 34989415
    [No Abstract]   [Full Text] [Related]  

  • 20. [The clinical and laboratory characteristics of congenital pyruvate kinase deficiency].
    Song L; Li Y; Peng GX; Zhang L; Jing LP; Zhou K; Li Y; Ye L; Li JP; Fan HH; Zhao X; Yang WR; Yang Y; Zhao YP; Xiong YZ; Wu ZJ; Zhang FK
    Zhonghua Nei Ke Za Zhi; 2018 Jul; 57(7):511-513. PubMed ID: 29996270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.